Table 1 General characteristics of the study population at baseline. Values are reported as mean ± SD and number (n) with percentage (%)
From: Right ventricle involvement in patients with breast cancer treated with chemotherapy
General Characteristics n = 83 patients | |
|---|---|
Age (years) | 55 ± 11 |
BMI (kg/m2) | 26.37 ± 4.35 |
BSA (m2) | 1.65 ± 0.3 |
Cigarette smoke % (n) | 41% (34) |
Hypertension % (n) | 30% (25) |
Family History of CVD % (n) | 16% (13) |
Dyslipidemia % (n) | 11% (9) |
Obesity % (n) | 10% (8) |
Type 2 diabetes % (n) | 5% (4) |
ACE-I % (n) | 10% (8) |
Beta-blockers % (n) | 10% (8) |
Statins % (n) | 7% (6) |
ARBs % (n) | 6% (5) |
Diuretics % (n) | 6% (5) |
Acetylsalicylic acid % (n) | 5% (4) |
Calcium antagonists % (n) | 2% (2) |
Radiotherapy % (n) | 19% (16) |
Trastuzumab % (n) | 18% (15) |
HFA-ICOS Low Risk % (n) | 65% (54) |
HFA-ICOS Moderate Risk % (n) | 32.5% (27) |
HFA-ICOS High Risk % (n) | 2.5% (2) |